Product
S95014
1 clinical trial
1 indication
Indication
Acute Lymphoblastic LeukemiaClinical trial
A Multicentre, Phase II Randomized Study, Open-label, With 2-arm Parallel Group, Comparing the Pharmacokinetics of the Liquid and the Lyophilized Formulations of Pegaspargase (S95014) in Treatment of Paediatric Patients With Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)Status: Completed, Estimated PCD: 2022-05-20